Prompt Diagnostics
Prompt Diagnostics is dedicated to making laboratory-quality molecular diagnostics accessible to everyone. Their mission is to provide fast, affordable, and easy-to-use diagnostic solutions with high sensitivity and specificity, enabling timely and targeted care from rural hospitals to urban clinics and developing countries. They develop innovative PCR-based platforms that deliver results in under 20 minutes, with connectivity, portability, and automation features, all at a fraction of the cost of traditional devices. The company is supported by notable organizations such as NIH, NSF, CARB-X, and Nucleate, and is moving to the LifeBridge Health BioIncubator in Baltimore, MD, to foster collaboration with healthcare and medtech innovators.
Industries
Nr. of Employees
small (1-50)
Prompt Diagnostics
2401 W. Belvedere Ave, Schapiro Bldg, Room 313, Baltimore, MD 21215
Products
Portable rapid PCR platform (sample-to-answer diagnostic system)
A portable diagnostic instrument and disposable cartridge system designed to perform automated sample processing and PCR-based multiplexed detection with on-board analysis and connectivity; engineered for reduced component count and lower cost relative to larger systems.
Platform applications for sexually transmitted infections and viral load quantitation
Demonstrated applications and peer-reviewed studies using a sample-to-answer magnetofluidic approach for detection of sexually transmitted infections, antimicrobial susceptibility, and viral load quantitation.
Portable rapid PCR platform (sample-to-answer diagnostic system)
A portable diagnostic instrument and disposable cartridge system designed to perform automated sample processing and PCR-based multiplexed detection with on-board analysis and connectivity; engineered for reduced component count and lower cost relative to larger systems.
Platform applications for sexually transmitted infections and viral load quantitation
Demonstrated applications and peer-reviewed studies using a sample-to-answer magnetofluidic approach for detection of sexually transmitted infections, antimicrobial susceptibility, and viral load quantitation.
Services
Design, optimization, and analytical validation of PCR/qPCR assays for infectious disease detection, including primer/probe design and performance characterization.
Rapid prototyping and iterative development of fluidic, thermal, and optical subsystems and integration with cartridge workflows and on-board data analysis.
Participation in grant- and partner-funded projects and incubator collaborations to advance diagnostic development and deployment in clinical and low-resource settings.
Design, optimization, and analytical validation of PCR/qPCR assays for infectious disease detection, including primer/probe design and performance characterization.
Rapid prototyping and iterative development of fluidic, thermal, and optical subsystems and integration with cartridge workflows and on-board data analysis.
Participation in grant- and partner-funded projects and incubator collaborations to advance diagnostic development and deployment in clinical and low-resource settings.
Expertise Areas
- Point-of-care molecular diagnostics
- Assay development and qPCR optimization
- Microfluidics and magnetofluidic cartridge systems
- Diagnostic instrumentation design and prototyping
Key Technologies
- Rapid PCR (sub-20-minute workflows)
- Quantitative PCR (qPCR)
- Magnetofluidic microfluidics
- Droplet magnetofluidics
News & Updates
Prompt Diagnostics LLC is moving to the LifeBridge Health BioIncubator in Baltimore, MD, to join a community of healthcare and medtech innovators.
Prompt’s recent funding from CARB-X and development of a rapid PCR platform were discussed in an article by 360Dx.
The NIH announced awards to support the development of advanced tech for HIV viral load detection, with Prompt Diagnostics involved.
CARB-X awarded Prompt $1 million to develop a portable PCR platform for detecting pathogenic bacteria and antibiotic susceptibility.
Development of a rapid, multiplexed point-of-care diagnostic platform for respiratory pathogens including SARS-CoV-2 variants.
A magnetofluidic platform designed for rapid detection of STIs and antimicrobial resistance at the point of care.
Prompt Diagnostics LLC is moving to the LifeBridge Health BioIncubator in Baltimore, MD, to join a community of healthcare and medtech innovators.
Prompt’s recent funding from CARB-X and development of a rapid PCR platform were discussed in an article by 360Dx.
The NIH announced awards to support the development of advanced tech for HIV viral load detection, with Prompt Diagnostics involved.
CARB-X awarded Prompt $1 million to develop a portable PCR platform for detecting pathogenic bacteria and antibiotic susceptibility.
Development of a rapid, multiplexed point-of-care diagnostic platform for respiratory pathogens including SARS-CoV-2 variants.
A magnetofluidic platform designed for rapid detection of STIs and antimicrobial resistance at the point of care.